<body><a name="drugname"></a><table class="topbox" width="100%">
<tr>
<td><span class="topboxgenname">INSULIN ZINC SUSPENSION, PROMPT (SEMILENTE)</span><br/>(in'su-lin)<br/><span class="topboxtradename">Semilente Insulin, </span><span class="topboxtradename">Semilente Purified Pork Insulin<br/></span><b>Classifications:</b> <span class="classification">hormone and synthetic substitute</span>; <span class="classification">antidiabetic agent</span><br/><b>Prototype: </b>Insulin Injection<br/><b>Pregnancy Category: </b>B<br/></td>
</tr>
</table>
<h1><a name="avail">Availability</a></h1>
<p>100 units/mL</p>
<h1><a name="action">Actions</a></h1>
<p>Rapid-acting cloudy suspension of insulin modified by addition of zinc chloride so that suspension is amorphous and therefore
         more quickly absorbed. Obtained from pork pancreas. Incidence of allergic reactions is low.
      </p>
<h1><a name="therapef">Therapeutic Effects</a></h1>
<p>It lowers blood glucose levels by increasing peripheral glucose uptake, especially by skeletal muscle and fat tissue, and
         by inhibiting the liver from changing glycogen to glucose.
      </p>
<h1><a name="uses">Uses</a></h1>
<p>Most commonly to supplement intermediate and long-acting insulins. Also for routine management of diabetes, especially for
         patients allergic to other types of insulin, and for patients with evidence of thrombotic phenomena in which protamine may
         be a factor.
      </p>
<h1><a name="contrain">Contraindications</a></h1>
<p>During episodes of hypoglycemia or in patients sensitive to any ingredient in the formulation.</p>
<h1><a name="precaution">Cautious Use</a></h1>
<p>In insulin resistant patients, hyperthyroidism or hypothyroidism; lactation, older adults, pregnancy (category B), renal or
         hepatic impairment. Safety and efficacy in children 
      </p><h1><a name="rtedsg">Route &amp; Dosage</a></h1>
<table cellpadding="4" cellspacing="0" class="rdbox" width="100%">
<tr>
<td><span class="indicationtitle">Diabetes Mellitus</span><br/><span class="rdage">Adult:</span> <span class="rdroute">IM/SC</span> Individualized doses (see <small>INSULIN INJECTION, REGULAR</small>)<br/></td>
</tr>
</table>
<h1><a name="admintn">Administration</a></h1><span class="adminroutetype">Subcutaneous/</span><span class="adminroutetype">Intramuscular</span><br/><ul>
<li>Give Semilente once daily, 30 min before breakfast. Additional doses may be required for some patients 30 min before a meal
            or at bedtime.
         </li>
<li>Ensure complete dispersion by mixing thoroughly by gently rotating vial between palms and by inverting it end-to-end several
            times. Do not shake.
         </li>
<li> 				Note: Zinc insulin preparations (Ultralente, Lente, Semilente) can be mixed with one another but they must <small>NOT</small> be mixed with other modified insulins. Do <small>NOT</small> mix insulins unless prescribed by physician. 			
         </li>
<li>Store unopened vial at 2°8° C (36°46° F). Avoid freezing and exposure to extremes in temperature
            or to direct sunlight.
         </li>
</ul>
<h1><a name="adverse">Adverse Effects (<img src="../images/special/greaterorequal.gif"/>1%)</a></h1>(see <small>INSULIN INJECTION, REGULAR</small>). 
      <h1><a name="interactions">Interactions</a></h1>(see <small>INSULIN INJECTION</small>). 
      <h1><a name="pharmaks">Pharmacokinetics</a></h1><span class="typehead">Onset:</span> 0.51 h. <span class="typehead">Peak:</span> 47 h. <span class="typehead">Duration:</span> 1216 h. <span class="typehead">Metabolism:</span> Metabolized in liver and kidney. <span class="typehead">Elimination:</span> Half-Life: Up to 13 h. 
      <h1><a name="nursing"><span class="implictitle">Nursing Implications</span></a></h1>
<p>(see <small>INSULIN INJECTION, REGULAR</small>)
      </p>
<p><span class="adeffecttitle">Patient &amp; Family Education</span></p>
<ul>
<li>Be alert for symptoms of hypoglycemia that are most apt to appear before lunch; glycosuria is most apt to appear during the
            night.
         </li>
<li>Do not breast feed while taking this drug without consulting physician.</li>
</ul>
<hr/>
<p><span class="footer">Common adverse effects in <i>italic</i>, life-threatening effects <u>underlined</u>; generic names in <b>bold</b>; classifications in <small>SMALL CAPS</small>; <img border="0" src="../images/maple.gif"/> Canadian drug name; <img border="0" src="../images/pr.gif"/> Prototype drug</span></p>
</body>